{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T02:37:52Z","timestamp":1761964672745},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,9,21]],"date-time":"2015-09-21T00:00:00Z","timestamp":1442793600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Angiogenesis"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s10456-015-9482-5","type":"journal-article","created":{"date-parts":[[2015,9,21]],"date-time":"2015-09-21T06:23:49Z","timestamp":1442816629000},"page":"511-524","source":"Crossref","is-referenced-by-count":24,"title":["Executive summary of the 11th HHT international scientific conference"],"prefix":"10.1007","volume":"18","author":[{"given":"Helen","family":"Arthur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urban","family":"Geisthoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James R.","family":"Gossage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher C. W.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Lacombe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary E.","family":"Meek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beth L.","family":"Roman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott O.","family":"Trerotola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastiaan","family":"Velthuis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Whitney","family":"Wooderchak-Donahue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,9,21]]},"reference":[{"key":"9482_CR1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/ng0294-205","volume":"6","author":"CL Shovlin","year":"1994","unstructured":"Shovlin CL, Hughes JM, Tuddenham EG, Temperley I, Perembelon YF, Scott J, Seidman CE, Seidman JG (1994) A gene for hereditary haemorrhagic telangiectasia maps to chromosome 9q3. Nat Genet 6:205\u2013209","journal-title":"Nat Genet"},{"key":"9482_CR2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/ng0696-189","volume":"13","author":"DW Johnson","year":"1996","unstructured":"Johnson DW, Berg JN, Baldwin MA, Gallione CJ, Marondel I, Yoon SJ, Stenzel TT, Speer M et al (1996) Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet 13:189\u2013195","journal-title":"Nat Genet"},{"key":"9482_CR3","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S0140-6736(04)15732-2","volume":"363","author":"CJ Gallione","year":"2004","unstructured":"Gallione CJ, Repetto GM, Legius E, Rustgi AK, Schelley SL, Tejpar S, Mitchell G, Drouin E et al (2004) A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). Lancet 363:852\u2013859","journal-title":"Lancet"},{"key":"9482_CR4","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1399-0004.2010.01596.x","volume":"79","author":"J McDonald","year":"2011","unstructured":"McDonald J, Damjanovich K, Millson A, Wooderchak W, Chibuk JM, Stevenson DA, Gedge F, Bayrak-Toydemir P (2011) Molecular diagnosis in hereditary hemorrhagic telangiectasia: findings in a series tested simultaneously by sequencing and deletion\/duplication analysis. Clin Genet 79:335\u2013344","journal-title":"Clin Genet"},{"key":"9482_CR5","doi-asserted-by":"crossref","unstructured":"McDonald J, Wooderchak-Donahue W, VanSant Webb C, Whitehead K, Stevenson DA, Bayrak-Toydemir P (2015) Hereditary hemorrhagic telangiectasia: genetics and molecular diagnostics in a new era. Front Genet 6(1):1\u20138. doi: 10.3389\/fgene.2015.00001","DOI":"10.3389\/fgene.2015.00001"},{"issue":"4","key":"9482_CR6","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/mus.24332","volume":"50","author":"K Bushby","year":"2014","unstructured":"Bushby K, Finkel R, Wong B, Barohn R, Campbell C, Comi GP, Connolly AM, Day JW et al (2014) Ataluren\u00a0treatment of patients with nonsense mutation dystrophinopathy. Muscle Nerve 50(4):477\u2013487","journal-title":"Muscle Nerve"},{"issue":"7","key":"9482_CR7","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S2213-2600(14)70100-6","volume":"2","author":"E Kerem","year":"2014","unstructured":"Kerem E, Konstan MW, De Boeck K, Accurso FJ, Sermet-Gaudelus I, Wilschanski M, Elborn JS et al (2014) Ataluren\u00a0for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial. Lancet Respir Med 2(7):539\u2013547","journal-title":"Lancet Respir Med"},{"key":"9482_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajhg.2013.07.004","volume":"93","author":"W Wooderchak-Donahue","year":"2013","unstructured":"Wooderchak-Donahue W, McDonald J, O\u2019Fallon B, Upton PD, Li W, Roman BL, Young S, Plant P et al (2013) BMP9 mutations cause a vascular anomaly syndrome with phenotypic overlap with hereditary hemorrhagic telangiectasia. Am J Hum Genet 93:1\u20138","journal-title":"Am J Hum Genet"},{"issue":"19","key":"9482_CR9","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1002\/ajmg.a.32468","volume":"146A","author":"CM Rigelsky","year":"2008","unstructured":"Rigelsky CM, Jennings C, Lehtonen R, Minai OA, Eng C, Aldred MA (2008) BMPR2 mutation in a patient with pulmonary arterial hypertension and suspected hereditary hemorrhagic telangiectasia. Am J Med Genet A 146A(19):2551\u20132556","journal-title":"Am J Med Genet A"},{"issue":"3","key":"9482_CR10","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.devcel.2012.02.005","volume":"22","author":"B Larriv\u00e9e","year":"2012","unstructured":"Larriv\u00e9e B, Prahst C, Gordon E, del Toro R, Mathivet T, Duarte A, Simons M, Eichmann A (2012) ALK1\u00a0signaling\u00a0inhibits angiogenesis by cooperating with the\u00a0Notch\u00a0pathway. Dev Cell 22(3):489\u2013500","journal-title":"Dev Cell"},{"key":"9482_CR11","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1378\/chest.12-0924","volume":"144","author":"R Cartin-Ceba","year":"2013","unstructured":"Cartin-Ceba R, Swanson KL, Krowka MJ (2013) Pulmonary arteriovenous malformations. Chest 144:1033\u20131044","journal-title":"Chest"},{"key":"9482_CR12","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1365-2796.2000.00725.x","volume":"248","author":"AD Kjeldsen","year":"2000","unstructured":"Kjeldsen AD, Oxhoj H, Andersen PE, Green A, Vase P (2000) Prevalence of pulmonary arteriovenous malformations (PAVM) and occurrence of neurological symptoms in patients with hereditary haemorrhagic telangiectasia (HHT). J Intern Med 248:255\u2013262","journal-title":"J Intern Med"},{"key":"9482_CR13","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1212\/WNL.55.7.959","volume":"55","author":"M Moussouttas","year":"2000","unstructured":"Moussouttas M, Fayad P, Rosenblatt M, Hashimoto M, Pollak J, Henderson K, Ma TY, White RI (2000) Pulmonary arteriovenous malformations: cerebral ischemia and neurologic manifestations. Neurology 55:959\u2013964","journal-title":"Neurology"},{"key":"9482_CR14","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/thx.2007.087452","volume":"63","author":"CL Shovlin","year":"2008","unstructured":"Shovlin CL, Jackson JE, Bamford KB, Jenkins IH, Benjamin AR, Ramadan H, Kulinskaya E (2008) Primary determinants of ischaemic stroke\/brain abscess risks are independent of severity of pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia. Thorax 63:259\u2013266","journal-title":"Thorax"},{"key":"9482_CR15","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1378\/chest.12-1599","volume":"144","author":"S Velthuis","year":"2013","unstructured":"Velthuis S, Buscarini E, van Gent MW, Gazzaniga P, Manfredi G, Danesino C, Schonewille WJ, Westermann CJ et al (2013) Grade of pulmonary right-to-left shunt on contrast echocardiography and cerebral complications: a striking association. Chest 144:542\u2013548","journal-title":"Chest"},{"key":"9482_CR16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/jmg.2009.069013","volume":"48","author":"ME Faughnan","year":"2011","unstructured":"Faughnan ME, Palda VA, Garcia-Tsao G, Geisthoff UW, McDonald J, Proctor DD, Spears J, Brown DH et al (2011) International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet 48:73\u201387","journal-title":"J Med Genet"},{"key":"9482_CR17","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.echo.2014.12.008","volume":"28","author":"S Velthuis","year":"2015","unstructured":"Velthuis S, Buscarini E, Gossage JR, Snijder RJ, Mager JJ, Post MC (2015) Clinical implications of pulmonary shunting on saline contrast echocardiography. J Am Soc Echocardiogr 28:255\u2013263","journal-title":"J Am Soc Echocardiogr"},{"key":"9482_CR18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.resp.2013.04.019","volume":"188","author":"JE Elliott","year":"2013","unstructured":"Elliott JE, Nigam SM, Laurie SS, Beasley KM, Goodman RD, Hawn JA, Gladstone IM, Chesnutt MS, Lovering AT (2013) Prevalence of left heart contrast in healthy, young, asymptomatic humans at rest breathing room air. Respir Physiol Neurobiol 188:71\u201378","journal-title":"Respir Physiol Neurobiol"},{"issue":"18","key":"9482_CR19","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1113\/jphysiol.2008.159350","volume":"586","author":"AT Lovering","year":"2008","unstructured":"Lovering AT, Stickland MK, Amann M, Murphy JC, O\u2019Brien MJ, Hokanson JS, Eldridge MW (2008) Hyperoxia prevents exercise-induced intrapulmonary arteriovenous shunt in healthy humans. J Physiol 586(18):4559\u20134565","journal-title":"J Physiol"},{"key":"9482_CR20","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/s00246-011-9917-8","volume":"32","author":"W Li","year":"2011","unstructured":"Li W, Niu B, Henderson K, Northrup V, Pollak JS, Trow T, Fahey J, White RI Jr (2011) Reproducibility of oxygen saturation monitoring during six-minute walk test and exercise stress test in patients with pulmonary arteriovenous malformations associated with hereditary hemorrhagic telangiectasia. Pediatr Cardiol 32:590\u2013594","journal-title":"Pediatr Cardiol"},{"key":"9482_CR21","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.jpeds.2004.08.046","volume":"145","author":"ME Faughnan","year":"2004","unstructured":"Faughnan ME, Thabet A, Mei-Zahav M, Colombo M, Maclusky I, Hyland RH, Pugash RA, Chait P, Henderson KJ, White RI (2004) Pulmonary arteriovenous malformations in children: outcomes of transcatheter embolotherapy. J Pediatr 145:826\u2013831","journal-title":"J Pediatr"},{"key":"9482_CR22","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/eurheartj\/ehp297","volume":"30","author":"N Gali\u00e8","year":"2009","unstructured":"Gali\u00e8 N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P et al (2009) Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 30:2493\u20132537","journal-title":"Eur Heart J"},{"key":"9482_CR23","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1006\/dbio.1999.9534","volume":"217","author":"HM Arthur","year":"2000","unstructured":"Arthur HM, Ure J, Smith AJ, Renforth G, Wilson DI, Torsney E, Charlton R, Parums DV et al (2000) Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development. Dev Biol 217:42\u201353","journal-title":"Dev Biol"},{"key":"9482_CR24","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI8088","volume":"104","author":"A Bourdeau","year":"1999","unstructured":"Bourdeau A, Dumont DJ, Letarte M (1999) A murine model of hereditary hemorrhagic telangiectasia. J Clin Invest 104:1343\u20131351","journal-title":"J Clin Invest"},{"key":"9482_CR25","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1161\/CIRCRESAHA.109.211037","volume":"106","author":"M Mahmoud","year":"2010","unstructured":"Mahmoud M, Allinson KR, Zhai Z, Oakenfull R, Ghandi P, Adams RH, Fruttiger M, Arthur HM (2010) Pathogenesis of arteriovenous malformations in the absence of endoglin. Circ Res 106:1425\u20131433","journal-title":"Circ Res"},{"key":"9482_CR26","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1073\/pnas.97.6.2626","volume":"97","author":"SP Oh","year":"2000","unstructured":"Oh SP, Seki T, Goss KA, Imamura T, Yi Y, Donahoe PK, Li L, Miyazono K et al (2000) Activin receptor-like kinase 1 modulates transforming growth factor-b1 signaling in the regulation of angiogenesis. Proc Natl Acad Sci USA 97:2626\u20132631","journal-title":"Proc Natl Acad Sci USA"},{"key":"9482_CR27","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1182\/blood-2007-08-107359","volume":"111","author":"SO Park","year":"2008","unstructured":"Park SO, Lee YJ, Seki T, Hong KH, Fliess N, Jiang Z, Park A, Wu X et al (2008) ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2. Blood 111:633\u2013642","journal-title":"Blood"},{"key":"9482_CR28","first-page":"3487","volume":"119","author":"SO Park","year":"2009","unstructured":"Park SO, Wankhede M, Lee YJ, Choi EJ, Fliess N, Choe SW, Oh SH, Walter G et al (2009) Real-time imaging of de novo arteriovenous malformation in a mouse model of hereditary hemorrhagic telangiectasia. J Clin Invest 119:3487\u20133496","journal-title":"J Clin Invest"},{"key":"9482_CR29","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1242\/dev.129.12.3009","volume":"129","author":"BL Roman","year":"2002","unstructured":"Roman BL, Pham VN, Lawson ND, Kulik M, Childs S, Lekven AC, Garrity DM, Moon RT et al (2002) Disruption of acvrl1 increases endothelial cell number in zebrafish cranial vessels. Development 129:3009\u20133019","journal-title":"Development"},{"key":"9482_CR30","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/hmg\/ddg050","volume":"12","author":"S Srinivasan","year":"2003","unstructured":"Srinivasan S, Hanes MA, Dickens T, Porteous ME, Oh SP, Hale LP, Marchuk DA (2003) A mouse model for hereditary hemorrhagic telangiectasia (HHT) type 2. Hum Mol Genet 12:473\u2013482","journal-title":"Hum Mol Genet"},{"key":"9482_CR31","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/81634","volume":"26","author":"LD Urness","year":"2000","unstructured":"Urness LD, Sorensen LK, Li DY (2000) Arteriovenous malformations in mice lacking activin receptor-like kinase-1. Nat Genet 26:328\u2013331","journal-title":"Nat Genet"},{"key":"9482_CR32","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0002-9440(10)64960-7","volume":"156","author":"A Bourdeau","year":"2000","unstructured":"Bourdeau A, Cymerman U, Paquet ME, Meschino W, McKinnon WC, Guttmacher AE, Becker L, Letarte M (2000) Endoglin expression is reduced in normal vessels but still detectable in arteriovenous malformations of patients with hereditary hemorrhagic telangiectasia type 1. Am J Pathol 156:911\u2013923","journal-title":"Am J Pathol"},{"key":"9482_CR33","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1158\/0008-5472.CAN-09-4466","volume":"70","author":"LJ Hawinkels","year":"2010","unstructured":"Hawinkels LJ, Kuiper P, Wiercinska E, Verspaget HW, Liu Z, Pardali E, Sier CF, ten Dijke P (2010) Matrix metalloproteinase-14 (MT1\u2013MMP)-mediated endoglin shedding inhibits tumor angiogenesis. Cancer Res 70:4141\u20134150","journal-title":"Cancer Res"},{"key":"9482_CR34","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1161\/CIRCULATIONAHA.112.101261","volume":"126","author":"AC Valbuena-Diez","year":"2012","unstructured":"Valbuena-Diez AC, Blanco FJ, Oujo B, Langa C, Gonzalez-Nunez M, Llano E, Pendas AM, Diaz M et al (2012) Oxysterol-induced soluble endoglin release and its involvement in hypertension. Circulation 126:2612\u20132624","journal-title":"Circulation"},{"issue":"4","key":"9482_CR35","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/hmg\/ddu531","volume":"24","author":"C Mallet","year":"2014","unstructured":"Mallet C, Lamribet K, Giraud S, Dupuis-Girod S, Feige JJ, Bailly S, Tillet E (2014) Functional analysis of endoglin mutations from hereditary hemorrhagic telangiectasia type 1 patients reveals different mechanisms for endoglin loss of function. Hum Mol Genet 24(4):1142\u20131154","journal-title":"Hum Mol Genet"},{"key":"9482_CR36","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1242\/dev.060467","volume":"138","author":"P Corti","year":"2011","unstructured":"Corti P, Young S, Chen CY, Patrick MJ, Rochon ER, Pekkan K, Roman BL (2011) Interaction between alk1 and blood flow in the development of arteriovenous malformations. Development 138:1573\u20131582","journal-title":"Development"},{"key":"9482_CR37","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1159\/000337762","volume":"33","author":"EJ Choi","year":"2012","unstructured":"Choi EJ, Walker EJ, Shen F, Oh SP, Arthur HM, Young WL, Su H (2012) Minimal homozygous endothelial deletion of Eng with VEGF stimulation is sufficient to cause cerebrovascular dysplasia in the adult mouse. Cerebrovasc Dis 33:540\u2013547","journal-title":"Cerebrovasc Dis"},{"key":"9482_CR38","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1161\/ATVBAHA.114.303984","volume":"34","author":"EM Garrido-Martin","year":"2014","unstructured":"Garrido-Martin EM, Nguyen HL, Cunningham TA, Choe SW, Jiang Z, Arthur HM, Lee YJ, Oh SP (2014) Common and distinctive pathogenetic features of arteriovenous malformations in hereditary hemorrhagic telangiectasia 1 and hereditary hemorrhagic telangiectasia 2 animal models\u2014brief report. Arterioscler Thromb Vasc Biol 34:2232\u20132236","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"9482_CR39","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s10456-014-9436-3","volume":"17","author":"C Han","year":"2014","unstructured":"Han C, Choe SW, Kim YH, Acharya AP, Keselowsky BG, Sorg BS, Lee YJ, Oh SP (2014) VEGF neutralization can prevent and normalize arteriovenous malformations in an animal model for hereditary hemorrhagic telangiectasia 2. Angiogenesis 17:823\u2013830","journal-title":"Angiogenesis"},{"key":"9482_CR40","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s12975-010-0020-x","volume":"1","author":"Q Hao","year":"2010","unstructured":"Hao Q, Zhu Y, Su H, Shen F, Yang GY, Kim H, Young WL (2010) VEGF induces more severe cerebrovascular dysplasia in endoglin than in alk1 mice. Transl Stroke Res 1:197\u2013201","journal-title":"Transl Stroke Res"},{"key":"9482_CR41","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/ana.22348","volume":"69","author":"EJ Walker","year":"2011","unstructured":"Walker EJ, Su H, Shen F, Choi EJ, Oh SP, Chen G, Lawton MT, Kim H et al (2011) Arteriovenous malformation in the adult mouse brain resembling the human disease. Ann Neurol 69:954\u2013962","journal-title":"Ann Neurol"},{"issue":"5","key":"9482_CR42","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/ajmg.a.31101","volume":"140","author":"P Bayrak-Toydemir","year":"2006","unstructured":"Bayrak-Toydemir P, McDonald J, Markewitz B, Lewin S, Miller F, Chou LS, Gedge F, Tang W et al (2006) Genotype\u2013phenotype correlation in hereditary hemorrhagic telangiectasia: mutations and manifestations. Am J Med Genet A 140(5):463\u2013470","journal-title":"Am J Med Genet A"},{"issue":"8","key":"9482_CR43","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/jmg.40.8.585","volume":"40","author":"J Berg","year":"2003","unstructured":"Berg J, Porteous M, Reinhardt D, Gallione C, Holloway S, Umasunthar T, Lux A, McKinnon W et al (2003) Hereditary haemorrhagic telangiectasia: a questionnaire based study to delineate the different phenotypes caused by endoglin and ALK1 mutations. J Med Genet 40(8):585\u2013590","journal-title":"J Med Genet"},{"issue":"4","key":"9482_CR44","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1365-2796.2005.01555.x","volume":"258","author":"AD Kjeldsen","year":"2005","unstructured":"Kjeldsen AD, M\u00f8ller TR, Brusgaard K, Vase P, Andersen PE (2005) Clinical symptoms according to genotype amongst patients with hereditary haemorrhagic telangiectasia. J Intern Med 258(4):349\u2013355","journal-title":"J Intern Med"},{"issue":"21","key":"9482_CR45","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1002\/ajmg.a.32243","volume":"146A","author":"TG Letteboer","year":"2008","unstructured":"Letteboer TG, Mager HJ, Snijder RJ, Lindhout D, Ploos van Amstel HK, Zanen P, Westermann KJ (2008) Genotype\u2013phenotype relationship for localization and age distribution of telangiectases in hereditary hemorrhagic telangiectasia. Am J Med Genet A 146A(21):2733\u20132739","journal-title":"Am J Med Genet A"},{"issue":"4","key":"9482_CR46","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1136\/jmg.2005.035451","volume":"43","author":"TG Letteboer","year":"2006","unstructured":"Letteboer TG, Mager JJ, Snijder RJ, Koeleman BP, Lindhout D, Ploos van Amstel JK, Westermann CJ (2006) Genotype\u2013phenotype relationship in hereditary haemorrhagic telangiectasia. J Med Genet 43(4):371\u2013377","journal-title":"J Med Genet"},{"issue":"6","key":"9482_CR47","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.blre.2010.07.001","volume":"24","author":"CL Shovlin","year":"2010","unstructured":"Shovlin CL (2010) Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment. Blood Rev 24(6):203\u2013219","journal-title":"Blood Rev"},{"issue":"3","key":"9482_CR48","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1161\/CIRCHEARTFAILURE.112.000206","volume":"6","author":"O Wever-Pinzon","year":"2013","unstructured":"Wever-Pinzon O, Selzman CH, Drakos SG, Saidi A, Stoddard GJ, Gilbert EM, Labedi M, Reid BB et al (2013) Pulsatility and the risk of nonsurgical bleeding in patients supported with the continuous-flow left ventricular assist device HeartMate II. Circ Heart Fail 6(3):517\u2013526","journal-title":"Circ Heart Fail"},{"issue":"6","key":"9482_CR49","doi-asserted-by":"crossref","first-page":"e98646","DOI":"10.1371\/journal.pone.0098646","volume":"9","author":"S Tual-Chalot","year":"2014","unstructured":"Tual-Chalot S, Mahmoud M, Allinson KR, Redgrave RE, Zhai Z, Oh SP, Fruttiger M, Arthur HM (2014) Endothelial depletion of Acvrl1 in mice leads to arteriovenous malformations associated with reduced endoglin expression. PLoS ONE 9(6):e98646","journal-title":"PLoS ONE"},{"issue":"47","key":"9482_CR50","doi-asserted-by":"crossref","first-page":"18940","DOI":"10.1073\/pnas.1310479110","volume":"110","author":"Y Yoshimatsu","year":"2013","unstructured":"Yoshimatsu Y, Lee YG, Akatsu Y, Taguchi L, Suzuki HI, Cunha SI, Maruyama K, Suzuki Y (2013) Bone morphogenetic protein-9 inhibits lymphatic vessel formation via activin receptor-like kinase 1 during development and cancer progression. Proc Natl Acad Sci USA 110(47):18940\u201318945","journal-title":"Proc Natl Acad Sci USA"},{"key":"9482_CR51","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/jth.12654","volume":"12","author":"S Gaillard","year":"2014","unstructured":"Gaillard S, Dupuis-Girod S, Boutitie F, Riviere S, Moriniere S, Hatron PY, Manfredi G, Kaminsky P et al (2014) Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a European cross-over controlled trial in a rare disease. J Thromb Haemost 12:1494\u20131502","journal-title":"J Thromb Haemost"},{"key":"9482_CR52","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.thromres.2014.06.012","volume":"134","author":"UW Geisthoff","year":"2014","unstructured":"Geisthoff UW, Seyfert UT, Kubler M, Bieg B, Plinkert PK, Konig J (2014) Treatment of epistaxis in hereditary hemorrhagic telangiectasia with tranexamic acid\u2014a double-blind placebo-controlled cross-over phase IIIB study. Thromb Res 134:565\u2013571","journal-title":"Thromb Res"},{"key":"9482_CR53","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000072411","volume":"110","author":"A Cirulli","year":"2003","unstructured":"Cirulli A, Liso A, D\u2019Ovidio F, Mestice A, Pasculli G, Gallitelli M, Rizzi R, Specchia G, Sabba C (2003) Vascular endothelial growth factor serum levels are elevated in patients with hereditary hemorrhagic telangiectasia. Acta Haematol 110:29\u201332","journal-title":"Acta Haematol"},{"key":"9482_CR54","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1001\/jama.2012.250","volume":"307","author":"S Dupuis-Girod","year":"2012","unstructured":"Dupuis-Girod S, Ginon I, Saurin JC, Marion D, Guillot E, Decullier E, Roux A, Carette MF et al (2012) Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output. JAMA 307:948\u2013955","journal-title":"JAMA"},{"key":"9482_CR55","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.2500\/ar.2014.5.0091","volume":"5","author":"AB Thompson","year":"2014","unstructured":"Thompson AB, Ross DA, Berard P, Figueroa-Bodine J, Livada N, Richer SL (2014) Very low dose bevacizumab for the treatment of epistaxis in patients with hereditary hemorrhagic telangiectasia. Allergy Rhinol 5:e91\u2013e95. doi: 10.2500\/ar.2014.5.0091","journal-title":"Allergy Rhinol"},{"issue":"6","key":"9482_CR56","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/hed.23655","volume":"37","author":"D Riss","year":"2015","unstructured":"Riss D, Burian M, Wolf A, Kranebitter V, Kaider A, Arnoldner C (2015) Intranasal submucosal bevacizumab for epistaxis in hereditary hemorrhagic telangiectasia: a double-blind, randomized, placebo-controlled trial. Head Neck 37(6):783\u2013787","journal-title":"Head Neck"},{"key":"9482_CR57","doi-asserted-by":"crossref","first-page":"794","DOI":"10.4161\/mabs.28025","volume":"6","author":"S Dupuis-Girod","year":"2014","unstructured":"Dupuis-Girod S, Ambrun A, Decullier E, Samson G, Roux A, Fargeton AE, Rioufol C, Schwiertz V et al (2014) ELLIPSE Study: a Phase 1 study evaluating the tolerance of bevacizumab nasal spray in the treatment of epistaxis in hereditary hemorrhagic telangiectasia. MAbs 6:794\u2013799","journal-title":"MAbs"},{"key":"9482_CR58","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nm.2131","volume":"16","author":"F Lebrin","year":"2010","unstructured":"Lebrin F, Srun S, Raymond K, Martin S, van den Brink S, Freitas C, Breant C, Mathivet T et al (2010) Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia. Nat Med 16:420\u2013428","journal-title":"Nat Med"},{"key":"9482_CR59","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/00005537-200404000-00021","volume":"114","author":"JJ Jameson","year":"2004","unstructured":"Jameson JJ, Cave DR (2004) Hormonal and antihormonal therapy for epistaxis in hereditary hemorrhagic telangiectasia. Laryngoscope 114:705\u2013709","journal-title":"Laryngoscope"},{"key":"9482_CR60","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/0140-6736(90)91010-8","volume":"335","author":"E Cutsem Van","year":"1990","unstructured":"Van Cutsem E, Rutgeerts P, Vantrappen G (1990) Treatment of bleeding gastrointestinal vascular malformations with oestrogen-progesterone. Lancet 335:953\u2013955","journal-title":"Lancet"},{"key":"9482_CR61","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.0954-6820.1981.tb11614.x","volume":"209","author":"P Vase","year":"1981","unstructured":"Vase P (1981) Estrogen treatment of hereditary hemorrhagic telangiectasia. A double-blind controlled clinical trial. Acta Med Scand 209:393\u2013396","journal-title":"Acta Med Scand"},{"key":"9482_CR62","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/000348940211100306","volume":"111","author":"W Bergler","year":"2002","unstructured":"Bergler W, Sadick H, Gotte K, Riedel F, Hormann K (2002) Topical estrogens combined with argon plasma coagulation in the management of epistaxis in hereditary hemorrhagic telangiectasia. Ann Otol Rhinol Laryngol 111:222\u2013228","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"9482_CR63","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/lary.20065","volume":"119","author":"E Yaniv","year":"2009","unstructured":"Yaniv E, Preis M, Hadar T, Shvero J, Haddad M (2009) Antiestrogen therapy for hereditary hemorrhagic telangiectasia: a double-blind placebo-controlled clinical trial. Laryngoscope 119:284\u2013288","journal-title":"Laryngoscope"},{"key":"9482_CR64","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1160\/TH09-07-0425","volume":"103","author":"Bernabeu-Herrero ME AlbinanaV","year":"2010","unstructured":"AlbinanaV Bernabeu-Herrero ME, Zarrabeitia R, Bernabeu C, Botella LM (2010) Estrogen therapy for hereditary haemorrhagic telangiectasia (HHT): effects of raloxifene, on endoglin and ALK1 expression in endothelial cells. Thromb Haemost 103:525\u2013534","journal-title":"Thromb Haemost"},{"key":"9482_CR65","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2147\/DDDT.S41756","volume":"7","author":"B Bjelakovic","year":"2013","unstructured":"Bjelakovic B, Bojanovic M, Lukic S, Saranac L, Vukomanovic V, Prijic S, Zivkovic N, Randjelovic D (2013) The therapeutic efficacy of propranolol in children with recurrent primary epistaxis. Drug Des Devel Ther 7:127\u2013129","journal-title":"Drug Des Devel Ther"},{"key":"9482_CR66","first-page":"85","volume":"47","author":"EM Gussem de","year":"2009","unstructured":"de Gussem EM, Snijder RJ, Disch FJ, Zanen P, Westermann CJ, Mager JJ (2009) The effect of N-acetylcysteine on epistaxis and quality of life in patients with HHT: a pilot study. Rhinology 47:85\u201388","journal-title":"Rhinology"},{"key":"9482_CR67","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/lary.23736","volume":"123","author":"DD Reh","year":"2013","unstructured":"Reh DD, Hur K, Merlo CA (2013) Efficacy of a topical sesame\/rose geranium oil compound in patients with hereditary hemorrhagic telangiectasia associated epistaxis. Laryngoscope 123:820\u2013822","journal-title":"Laryngoscope"},{"key":"9482_CR68","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1378\/chest.117.1.31","volume":"117","author":"ME Faughnan","year":"2000","unstructured":"Faughnan ME, Lui YW, Wirth JA, Pugash RA, Redelmeier DA, Hyland RH, White RI (2000) Diffuse pulmonary arteriovenous malformations: characteristics and prognosis. Chest 117:31\u201338","journal-title":"Chest"},{"key":"9482_CR69","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.diii.2013.03.014","volume":"94","author":"P Lacombe","year":"2013","unstructured":"Lacombe P, Lacout A, Marcy PY, Binsse S, Sellier J, Bensalah M, Chinet T, Bourgault-Villada I et al (2013) Diagnosis and treatment of pulmonary arteriovenous malformations in hereditary hemorrhagic telangiectasia: an overview. Diagn Interv Imaging 94:835\u2013848","journal-title":"Diagn Interv Imaging"},{"key":"9482_CR70","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s00270-003-0263-y","volume":"28","author":"P Lacombe","year":"2005","unstructured":"Lacombe P, Lagrange C, El Hajjam M, Chinet T, Pelage JP (2005) Reperfusion of complex pulmonary arteriovenous malformations after embolization: report of three cases. Cardiovasc Intervent Radiol 28:30\u201335","journal-title":"Cardiovasc Intervent Radiol"},{"key":"9482_CR71","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1097\/01.RVI.0000182163.25493.BB","volume":"16","author":"A Milic","year":"2005","unstructured":"Milic A, Chan RP, Cohen JH, Faughnan ME (2005) Reperfusion of pulmonary arteriovenous malformations after embolotherapy. J Vasc Interv Radiol 16:1675\u20131683","journal-title":"J Vasc Interv Radiol"},{"key":"9482_CR72","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/01.RVI.0000191410.13974.B6","volume":"17","author":"JS Pollak","year":"2006","unstructured":"Pollak JS, Saluja S, Thabet A, Henderson KJ, Denbow N, White RI (2006) Clinical and anatomic outcomes after embolotherapy of pulmonary arteriovenous malformations. J Vasc Interv Radiol 17:35\u201345","journal-title":"J Vasc Interv Radiol"},{"key":"9482_CR73","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1148\/radiol.2421041571","volume":"242","author":"PY Brillet","year":"2007","unstructured":"Brillet PY, Dumont P, Bouaziz N, Duhamel A, Laurent F, Remy J, Remy-Jardin M (2007) Pulmonary arteriovenous malformation treated with embolotherapy: systemic collateral supply at multidetector CT angiography after 2\u201320-year follow-up. Radiology 242:267\u2013276","journal-title":"Radiology"}],"container-title":["Angiogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-015-9482-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10456-015-9482-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-015-9482-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,22]],"date-time":"2022-05-22T02:09:55Z","timestamp":1653185395000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10456-015-9482-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,21]]},"references-count":73,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["9482"],"URL":"https:\/\/doi.org\/10.1007\/s10456-015-9482-5","relation":{},"ISSN":["0969-6970","1573-7209"],"issn-type":[{"value":"0969-6970","type":"print"},{"value":"1573-7209","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,21]]}}}